aerrane 100 tekutina k inhalaci parou - otsingu tulemused

Euroopa Liit - taani - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiske midler - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

erwinase 10.000 e pulver til injektions-/infusionsvæske, opløsning

porton biopharma limited - crisantaspase - pulver til injektions-/infusionsvæske, opløsning - 10.000 e

Euroopa Liit - taani - EMA (European Medicines Agency)

tevimbra

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastiske midler - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.

Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

alcartis 10 mg smeltetabletter

egis pharmaceuticals plc - aripiprazol - smeltetabletter - 10 mg

Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

alcartis 15 mg smeltetabletter

egis pharmaceuticals plc - aripiprazol - smeltetabletter - 15 mg

Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

alcartis 30 mg smeltetabletter

egis pharmaceuticals plc - aripiprazol - smeltetabletter - 30 mg

Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

alcartis 5 mg smeltetabletter

egis pharmaceuticals plc - aripiprazol - smeltetabletter - 5 mg